ADM is a complex process that is considered the first step in the development of pancreatic cancer induced by oncogenic K-rasG12D, substantially accelerating the development of PDAC via abnormal inflammatory and growth factor signaling through cell surface receptors [34,35]. The gene discussed is CD177; the disease is familial pancreatic carcinoma.